Your session is about to expire
← Back to Search
Mental Health Screenings for African-American Children's Well-being
N/A
Waitlist Available
Led By Joni Splett, Ph.D
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from first day of school in year 1 to last day of school in year 2
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare two different school-based mental health screenings to see which one is more effective in getting elementary school students the mental health services they need.
Who is the study for?
This trial is for elementary school students at certain schools where the study is taking place. It's aimed to help African-American children with mental health needs. Children who are under the care of the state or any institution other than their family cannot participate.
What is being tested?
The study is testing two methods: one group will receive a basic mental health screening, while another group gets an enhanced screening process. The goal is to see which method leads to better access and use of mental health services.
What are the potential side effects?
Since this trial involves non-medical interventions like screenings, there aren't typical medical side effects. However, participants may experience emotional discomfort or stress during the mental health evaluation process.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from first day of school in year 1 to last day of school in year 2
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from first day of school in year 1 to last day of school in year 2
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Mean change from baseline in student referral to a mental health intervention as measured by the number of students referred to mental health interventions each quarter
Secondary study objectives
Mean change from baseline in student disciplinary encounters as measured by the number of Office Discipline Referrals each quarter
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: EnhancedExperimental Treatment1 Intervention
The enhanced arm involves the enhancements to school-based mental health (SBMH) of the comparator arm with the addition of 3 additional empirically supported enhancements to mental health screening: 1) voluntary school teams will review screening and service receipt data disaggregated by racial/ethnic subgroups to identify and problem solve inequities; 2) Unintentional bias training for voluntary school teams, involving teaching participants to conceptualize prejudice as well as strategies to reduce bias; and 3) Mental Health Literacy training for voluntary school teams in awareness and understanding of students' mental health well-being and need for intervention.
Group II: ComparatorActive Control1 Intervention
The comparator arm enhances school-based mental health (SBMH) with universal screening and trains voluntary school teams to use the school-wide data to plan and make intervention referrals using an evidence-based in-service training and coaching model called Team-Initiated Problem Solving (TIPS).
Find a Location
Who is running the clinical trial?
University of FloridaLead Sponsor
1,409 Previous Clinical Trials
748,117 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
580 Previous Clinical Trials
27,086,153 Total Patients Enrolled
3 Trials studying Mental Health
3,465 Patients Enrolled for Mental Health
Joni Splett, Ph.DPrincipal InvestigatorUniversity of Florida
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Enhanced
- Group 2: Comparator
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.